Efficacy-Implementation Study for PC CARES in Rural Alaska
Launched by UNIVERSITY OF MICHIGAN · Oct 23, 2024
Trial Information
Current as of November 14, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called PC CARES, is focused on preventing suicide in rural Alaska communities by promoting conversations about mental health and research. The study aims to see how well a program called Learning Circles helps people in these communities and whether it can positively affect young people’s mental health. Researchers also want to find ways to expand this program to other Alaska Native communities to ensure more people can benefit.
Anyone aged 12 and older who lives or works in the participating communities can join the study. If you decide to take part, you can expect to engage in discussions and activities that promote mental health awareness and support. The trial is currently recruiting participants, and it’s a great opportunity to contribute to important research that could help save lives in your community.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Anyone aged 12 and over who lives or works in the designated communities may participate in this study.
About University Of Michigan
The University of Michigan, a leading academic institution renowned for its commitment to advancing healthcare and medical research, serves as a prominent clinical trial sponsor. With a robust infrastructure that supports innovative research initiatives, the university leverages its multidisciplinary expertise to conduct a wide array of clinical trials aimed at improving patient outcomes and advancing medical knowledge. Through its state-of-the-art facilities and collaborative environment, the University of Michigan fosters partnerships between researchers, clinicians, and industry leaders, ensuring the development of cutting-edge therapies and interventions that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ann Arbor, Michigan, United States
Fairbanks, Alaska, United States
Patients applied
Trial Officials
Lisa Wexler, PhD
Principal Investigator
Univer
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported